Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation

Journal of Human Reproductive Sciences

Volumn 6, Issue 4, 2013, Pages 227-234

  Raju, Gottumukkala Achyuta Rama ^a   Chavan, Rahul ^a,h   Deenadayal, Mamata ^b   Gunasheela, Devika ^c,i   Gutgutia, Rohit ^d   Haripriya, Geetha ^e   Govindarajan, Mirudhubashini ^f   Patel, Nayana Hitesh ^b   Patki, Ameet Shashikant ^g  

^a Krishna IVF Clinic   (India)

^b Infertility Institute and Research Centre ^*  (India)

^c Departments of Reproductive Medicine   (India)

^d NOVA IVI Fertility   (India)

^e Department of Diabetology   (India)

^f Women's Center and Hospital   (India)

^g Fertility Associates   (India)

^h Gunasheela Institute Res for Repro   (India)

ⁱ Merck Specialities Private Limited   (India)

Author keywords

Assisted reproductive techniques; Follicle stimulating hormone; Luteinizing hormone; Ovarian hyper stimulation

Indexed keywords

FOLLITROPIN; FOLLITROPIN RECEPTOR; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

FOLLICLE STIMULATING HORMONE RECEPTOR GENE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INFERTILITY THERAPY; OPEN STUDY; OVARIAN RESERVE; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY MECHANISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 85014140440     PISSN: 09741208     EISSN: 19984766     Source Type: Journal    
DOI: 10.4103/0974-1208.126285     Document Type: Review

References (57)

1. Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 2002;77:1170-7.
2. Humaidan P, Bungum L, Bungum M, Andersen CY. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 2002;17:2016-21.
3. Lahoud R, Al-Jefout M, Tyler J, Ryan J, Driscoll G. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates. Hum Reprod 2006;21:2645-9.
4. Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertil Steril 2007;87:542-6.
5. Pezzuto A, Ferrari B, Coppola F, Nardelli GB. LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels. Gynecol Endocrinol 2010;26:118-24.
6. Wong PC, Qiao J, Ho C, Ramaraju GA, Wiweko B, Takehara Y, et al. Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: An Asian perspective. Reprod Biomed Online 2011;23:81-90.
7. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Pellicer A. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: An age-adjusted analysis. Fertil Steril 2011;95:1031-6.
8. O'Dea L, O'Brien F, Currie K, Hemsey G. Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: Evidence of a threshold effect. Curr Med Res Opin 2008;24:2785-93.
9. Vaskivuo T. Regulation of Apoptosis in the Female Reproductive System. PhD [dissertation]. Oulu, Finland: University of Oulu; 2002.
10. Brown JB. Pituitary control of ovarian function-Concepts derived from gonadotrophin therapy. Aust N Z J Obstet Gynaecol 1978;18:46-54.
11. Goncalves PB, Portela VM, Ferreira R, Gasperin BG. Role of angiotensin II on follicle development and ovulation. Anim Reprod 2010;7:140-5.
12. Kronenberg HM, Memed S, Polonsky KS, Larsen PR. Williams Textbook of Endocrinology. 11th ed. Philadelphia: Saunders Elsevier; 2007.
13. Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams Textbook of Endocrinology. 12th ed. PA: Saunders Elsevier; 2011.
14. Fortune JE, Quirk SM. Regulation of steroidogenesis in bovine preovulatory follicles. J Anim Sci 1988;66 Suppl 2:1-8.
15. Richards JS, Pangas SA. The ovary: Basic biology and clinical implications. J Clin Invest 2010;120:963-72.
16. De Souza MJ, Miller BE, Loucks AB, Luciano AA, Pescatello LS, Campbell CG, et al. High frequency of luteal phase deficiency and anovulation in recreational women runners: Blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. J Clin Endocrinol Metab 1998;83:4220-32.
17. Fauser BC, Van Heusden AM. Manipulation of human ovarian function: Physiological concepts and clinical consequences. Endocr Rev 1997;18:71-106.
18. Sullivan MW, Stewart-Akers A, Krasnow JS, Berga SL, Zeleznik AJ. Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): A role for LH in the final stages of follicular maturation. J Clin Endocrinol Metab 1999;84:228-32.
19. Loumaye E, Engrand P, Shoham Z, Hillier SG, Baird DT. Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Hum Reprod 2003;18:314-22.
20. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: Analysis of over 4000 cycles. Hum Reprod 2010;25:2092-100.
21. Bosch E, Valencia I, Escudero E, Crespo J, Simon C, Remohi J, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 2003;80:1444-9.
22. Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Spettoli D, Taraborrelli S, et al. Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration. Hum Reprod 2002;17:2009-15.
23. Palermo R. Differential actions of FSH and LH during folliculogenesis. Reprod Biomed Online 2007;15:326-37.
24. Voutilainen R, Tapanainen J, Chung BC, Matteson KJ, Miller WL. Hormonal regulation of P450scc (20,22-desmolase) and P450c17 (17 alpha-hydroxylase/17,20-lyase) in cultured human granulosa cells. J Clin Endocrinol Metab 1986;63:202-7.
25. Raju GA, Teng SC, Kavitha P, Lakshmi BK, Ravikrishna C. Combination of recombinant follicle stimulating hormone with human menopausal gonadotrophin or recombinant luteinizing hormone in a long gonadotrophin-releasing hormone agonist protocol: a retrospective study. Reprod Med Biol 2012;11:129-33.
26. Hill MJ, Levy G, Levens ED. Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature. Reprod Biomed Online 2012;24:261-71.
27. Simoni M, Tempfer CB, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update 2008;14:459-84.
28. Simoni M, Tuttelmann F, Michel C, Bockenfeld Y, Nieschlag E, Gromoll J. Polymorphisms of the luteinizing hormone/chorionic gonadotropin receptor gene: Association with maldescended testes and male infertility. Pharmacogenet Genomics 2008;18:193-200.
29. Themmen AP. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 2005;130:263-74.
30. Nilsson CH, Kaleva M, Virtanen H, Haavisto AM, Pettersson K, Huhtaniemi IT. Disparate response of wild-type and variant forms of LH to GnRH stimulation in individuals heterozygous for the LHbeta variant allele. Hum Reprod 2001;16:230-5.
31. Pettersson KS, Soderholm JR. Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies. Clin Chem 1991;37:333-40.
32. Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, et al. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online 2009;18:9-14.
33. Mafra FA, Bianco B, Christofolini DM, Souza AM, Zulli K, Barbosa CP. Luteinizing hormone beta-subunit gene (LHbeta) polymorphism in infertility and endometriosis-associated infertility. Eur J Obstet Gynecol Reprod Biol 2010;151:66-9.
34. Hamilton-Fairley D, Kiddy D, Watson H, Sagle M, Franks S. Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum Reprod 1991;6:1095-9.
35. Shoham Z, Patel A, Jacobs HS. Polycystic ovarian syndrome: Safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone. Fertil Steril 1991;55:1051-6.
36. Hedon B, Hugues JN, Emperaire JC, Chabaud JJ, Barbereau D, Boujenah A, et al. A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women. Hum Reprod 1998;13:2688-92.
37. Leader A, Monofollicular Ovulation Induction Study Group. Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low-dose step-up protocol with weekly increments of 25 international units of follicle-stimulating hormone. Fertil Steril 2006;85:1766-73.
38. Hugues JN, Cedrin-Durnerin I, Avril C, Bulwa S, Herve F, Uzan M. Sequential step-up and step-down dose regimen: An alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome. Hum Reprod 1996;11:2581-4.
39. Hillier SG, Ross GT. Effects of exogenous testosterone on ovarian weight, follicular morphology and intraovarian progesterone concentration in estrogen-primed hypophysectomized immature female rats. Biol Reprod 1979;20:261-8.
40. De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, et al. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005;20:390-6.
41. Ubaldi FM, Rienzi L, Ferrero S, Baroni E, Sapienza F, Cobellis L, et al. Management of poor responders in IVF. Reprod Biomed Online 2005;10:235-46.
42. Hill MJ, Levens ED, Levy G, Ryan ME, Csokmay JM, DeCherney AH, et al. The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: A systematic review and meta-analysis. Fertil Steril 2012;97:1108-14.
43. Musters AM, van Wely M, Mastenbroek S, Kaaijk EM, Repping S, van der Veen F, et al. The effect of recombinant LH on embryo quality: A randomized controlled trial in women with poor ovarian reserve. Hum Reprod 2012;27:244-50.
44. Barrenetxea G, Agirregoikoa JA, Jimenez MR, de Larruzea AL, Ganzabal T, Carbonero K. Ovarian response and pregnancy outcome in poor-responder women: A randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 2008;89:546-53.
45. Bosdou JK, Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Zepiridis L, et al. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: A systematic review and meta-analysis. Hum Reprod Update 2012;18:127-45.
46. Mochtar MH, Van der Veen, Ziech M, van Wely M. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2007;2:CD005070.
47. Nakahara K, Saito H, Saito T, Ito M, Ohta N, Sakai N, et al. Incidence of apoptotic bodies in membrana granulosa of the patients participating in an in vitro fertilization program. Fertil Steril 1997;67:302-8.
48. Oosterhuis GJ, Michgelsen HW, Lambalk CB, Schoemaker J, Vermes I. Apoptotic cell death in human granulosa-lutein cells: A possible indicator of in vitro fertilization outcome. Fertil Steril 1998;70:747-9.
49. Bencomo E, Perez R, Arteaga MF, Acosta E, Pena O, Lopez L, et al. Apoptosis of cultured granulosa-lutein cells is reduced by insulin-like growth factor I and may correlate with embryo fragmentation and pregnancy rate. Fertil Steril 2006;85:474-80.
50. Gatta V, Tatone C, Ciriminna R, Vento M, Franchi S, d'Aurora M, et al. Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone+recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone. Fertil Steril 2013;99:2000-81.
51. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;84:2951-6.
52. Thornton K, Alper MM, Ryley D, Ezcurra D. Outcomes of GnRH antagonist IVF cycles using LH supplementation for COH: FSH/rhLH versus FSH/hMG. Fertil Steril 2006;86:S411.
53. Rekha P, Jirge S. Is LH necessary in ovulation induction? In: Desai S, Parihar M, Allahabadia G, editors. Infertility: Principles and Practice. India: BI Publications Pvt. Ltd.; 2004. p. 5.
54. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH-and FSH-deficient anovulatory women: A dose-finding study. The European Recombinant Human LH Study Group. J Clin Endocrinol Metab 1998;83:1507-14.
55. Lisi F, Caserta D, Montanino M, Berlinghieri V, Bielli W, Carfagna P, et al. Recombinant luteinizing hormone priming in multiple follicular stimulation for in-vitro fertilization in downregulated patients. Gynecol Endocrinol 2012;28:674-7.
56. Carone D, Vizziello G, Vitti A, Chiappetta R. Clinical outcomes of ovulation induction in WHO Group I anovulatory women using r-hFSH ? r-hLH in a 2:1 ratio compared to hMG. Hum Reprod 2010;25:285-321.
57. Ferraretti AP, Gianaroli L, Magli MC, D'angelo A, Farfalli V, Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004;82:1521-6.